ð ç« æ«éèš
- EBV: dsDNA herpesvirus, B cells + epithelial cells, lifetime latency
- Universal infection (95%+ adults)
- IM (kissing disease): fever + pharyngitis + posterior cervical LAP + splenomegaly + atypical lymphocytes + monospot+
- Amoxicillin rash in EBV = pathognomonic (NOT allergy)
- Contact sports avoidance à 3-4 wk (splenic rupture)
- Cancer associations: Burkitt, NPC (Taiwan!), gastric, Hodgkin, NK/T-cell, PTLD, primary CNS lymphoma in HIV
- 2022 game changer (Bjornevik et al.): EBV strongly associated with MS â necessary trigger
- XLP: SH2D1A â fulminant IM + lymphoma
- PTLD: reduce immunosuppression + rituximab + EBV-specific T cells
- Treatment: supportive for IM; no antiviral (acyclovir minimal effect); steroid only for complications
- Plasma EBV DNA = NPC prognostic biomarker (Taiwan endemic)
- ç§é«åž« hint: è幎 + äžæ LAP + Taiwan/Asia â NPC ALWAYS; EBV PCR + 圱å + biopsy